3SBio, Inc
- Biotech or pharma, therapeutic R&D
3SBio is seeking out-licensing partners for a diverse portfolio of innovative biologics. Our pipeline includes first-in-class and best-in-class candidates featuring long-acting monoclonal antibodies, bispecific antibodies, and bifunctional fusion proteins targeting multiple therapeutic areas, including oncology, nephrology, autoimmune diseases, metabolic disorders, and dermatology. We will not accept service provider meeting request at this conference. We appreciate your understanding.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}